ijms-logo

Journal Browser

Journal Browser

Molecular Research in Cardiovascular Disease, 3rd Edition

Special Issue Editor


E-Mail Website
Guest Editor
1. Corresponding Member of the Romanian Academiy, 125, Calea Victoriei, Sector 1, RO-010071 Bucharest, Romania
2. Department 4-Cardiothoracic Pathology, University of Medicine and Pharmacy Carol Davila, 8, Eroii Sanitari Bvd., 050474 Bucharest, Romania
Interests: ischemic heart disease; atherosclerosis; molecular mechanisms of acute coronary syndromes; arterial hypertension; hypertensive target organ damage
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Cardiovascular diseases (CVD) are the leading cause of death worldwide. Atherosclerosis, the dominant driver of CVD, is characterized by a process of chronic inflammation and endothelial dysfunction associated with vessel wall accumulation of oxidized low-density lipoproteins.

In advanced stages, endothelial lesions promote atherosclerotic plaque instability, acute events, and ultimately, plaque rupture.

The molecular and cellular mechanisms underlying various cardiovascular diseases are not completely understood. However, several signaling pathways that induce vascular remodeling are essential in both coronary heart disease and in related pathologies, such as pulmonary artery hypertension, suggesting the existence of common mechanisms in these maladies.

With this Special Issue, we aim to present representative data obtained at the interface between basic science and clinical research on the molecular mechanisms of heart and vascular diseases and the novel biomarkers and molecules that can become specific targets for future therapeutic interventions. In addition, we hope that the papers presented will inspire novel innovative investigations at the bench to bedside intersection.

Due to the success of the first and second editions of this Special Issue, we would like to add more results and new insights from recent research projects (https://www.mdpi.com/journal/ijms/special_issues/Molecular_Research_Cardiovascular_Disease, https://www.mdpi.com/journal/ijms/special_issues/Cardiovascular_Disease_2).

Prof. Dr. Maria Dorobantu
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • atherosclerosis
  • cardiovascular disease
  • endothelial cells
  • matrix metalloproteinases
  • biomarkers
  • miRNAs
  • epigenetics

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue policies can be found here.

Related Special Issues

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

13 pages, 1897 KiB  
Article
Natriuretic Peptides and Soluble ST2 Improve Echocardiographic and Invasive Long-Term Survival Prediction in Patients Evaluated for Diastolic Dysfunction
by Horațiu Suciu, Paul-Adrian Călburean, Adina Huțanu, Mădălina Oprica, Diana Roxana Opriș, Anda-Cristina Scurtu, Alexandru Stan, David Aniței, Klara Brînzaniuc, László Hadadi and Marius Harpa
Int. J. Mol. Sci. 2025, 26(8), 3713; https://doi.org/10.3390/ijms26083713 - 14 Apr 2025
Viewed by 232
Abstract
This study aimed to investigate the impact of long-term survival on cardiac serum biomarkers such as natriuretic peptides (mid-regional pro-atrial natriuretic peptide [MR-proANP], B-type natriuretic peptide [BNP], N-terminal prohormone BNP [NT-proBNP]), soluble ST2 (sST2), galectin-3 and mid-regional pro-adrenomedullin (MR-proAMD). Consecutive patients hospitalized in [...] Read more.
This study aimed to investigate the impact of long-term survival on cardiac serum biomarkers such as natriuretic peptides (mid-regional pro-atrial natriuretic peptide [MR-proANP], B-type natriuretic peptide [BNP], N-terminal prohormone BNP [NT-proBNP]), soluble ST2 (sST2), galectin-3 and mid-regional pro-adrenomedullin (MR-proAMD). Consecutive patients hospitalized in a tertiary center, undergoing echocardiographic and invasive left cardiac catheterization for diastolic dysfunction assessment were prospectively included in this study. Cardiac biomarkers were determined from pre-procedural peripheral venous blood samples. A total of 110 patients were included, with a median follow-up of 1.66 (1.23–2.16) years during which 16 (14.5%) patients died. A total of 45.4% (50) of patients had diastolic dysfunction. In the univariate Cox regression, long-term survival was predicted by BNP (p < 0.0001, HR = 0.39 [0.20–0.53]), NT-proBNP (p < 0.0001, HR = 0.40 [0.22–0.55]), MR-proANP (p = 0.001, HR = 0.30 [0.11–0.46]), sST2 (p < 0.0001, HR = 0.47 [0.30–0.60]), but not with MR-proAMD (p = 0.77) or galectin-3 (p = 0.76). In the final stepwise multivariable Cox regression non-invasive and invasive models, NT-proBNP and sST2 remained independent predictors of survival. Natriuretic peptides (BNP and NT-proBNP) and sST2 were predictors of long-term survival, while MR-proANP, MR-proADM and galectin-3 did not have predictive values. NT-proBNP and sST2 improved survival prediction in both a non-invasive scenario (including clinical, serum and echocardiographic parameters) and an invasive clinical scenario (including left heart catheterization parameters). The sST2 pathway could provide a target for therapeutic intervention. Full article
(This article belongs to the Special Issue Molecular Research in Cardiovascular Disease, 3rd Edition)
Show Figures

Figure 1

Back to TopTop